Objectives: To examine the immunological and clinical influence of 4 months' feeding with either yoghurt or partially skimmed milk or nothing, on 20 volunteers. Subjects: Thirteen subjects had a demonstrated allergic rhinopathy and seven were healthy subjects and participated as controls.
Introduction
There have been numerous reports on the potentially beneficial effects of consumption of yoghurt and dairy products containing lactic acid bacteria by either patients with allergic diseases (Wheeler et al, 1997a,b; Van de Water et al, 1999) healthy volunteers (Arunachalam et al, 2000; Chen et al, 1999; Halpern et al, 1991; Yoon et al, 1999; Solis-Pereyra et al, 1997) and laboratory animals (Solis Pereyra et al, 1997; Perdigon et al, 1998; Ha et al, 1999) .
In a very instructive review, Meydani and Ha (2000) examined the bacterial and nonbacterial components of yoghurt with potential immunostimulatory effects. Indeed, after Metchnikoff (1908) hypothesized that lactic acid bacteria (LAB) such as Lactobacillus bulgaricus and Streptococcus thermophilus could suppress toxins produced by intestinal putrefactive bacteria, the leading themes supporting the use of yoghurt have been to maintain or to reconstitute the bacterial flora and the normal function of the immune system. Owing to its complexity, it has become difficult to select systemic biomarkers for evaluating the immunoregulatory properties of yoghurt. Thus, although Meydani and Ha (2000) remarked that an increased yoghurt consumption, particularly in elderly and immunocompromised patients may be useful, owing to lack of controls, short duration of studies, inappropriate designs and variability of individual responses, we remain as yet uncertain on the validity of the use of yoghurt.
Our interest in this problem stems from the old postulation that a physiologic cytokine production takes place continuously mostly due to interaction among luminal gut compounds such as peptidoglycans, traces of lipopolysaccharides, muramylpeptides and free fatty acids generated by fermented milk and the gut associated lymphoid tissue (GALT; Bocci, 1981 Bocci, , 1988 Bocci, , 1992 . The localized and basic production of cytokines represents a crucial factor in priming and balancing the reactivity of immune cells, allowing resistance against pathogens and avoiding hyperegic reactions. This concept has been supported by corroborative studies by De Simone et al (1988) , Halpern et al (1991) , Trapp et al (1993) and Solis-Pereyra et al (1997) . However no significant improvement of several immune parameters were reported in atopic individuals, who received yoghurt vs milk in a randomized cross-over design by Wheeler et al, (1997a, b) .
Our study was designed to evaluate the controversial impact of yoghurt on the immune function of patients affected by allergic rhinitis fed either yoghurt containing live active bacteria or partially skimmed milk for 4 months. Our study has been performed with a potentiated yoghurt labelled Kyr# by the producer. This product should be more active than usual yoghurt as it also contains probiotic bacterial strains. It is known that defective interferon g (IFNg) production or=and an imbalance between IFNg and Interleukin-4 (IL-4) characterizes atopic dermatitis and asthma (Tang et al, 1993; Campbell et al 1999) . This situation suggested a CD4
þ Th2 predominance and we thought it worthwhile to examine whether dietary yoghurt fed to naive subjects might adjust the balance between Th1 and Th2 type lymphocytes.
Materials and methods

Subjects
Thirteen patients (six women and seven men) aged between 19 and 44 y periodically visiting the ENT clinic participated. The patients, all of whom volunteered, were recruited in a homogeneous manner, having a relatively small age range not over 44 y of age, so as to have a good allergic and immunological reactivity. They had a well documented clinical history of nasal allergy but no other health problems.
Of the five healthy subjects two dropped out of the study due to work commitments. This problem was partly overcome by including at a later stage four new healthy subjects. This addition has allowed us to achieve a more homogenous reference value.
Informed consent was obtained from all subjects and the study was approved by the Ethics Committee of the University of Siena, Italy.
Criteria for defining nasal allergy All subjects underwent an accurate anamnesis, focused on signs and symptoms of allergic rhinopathy, with particular attention to in-season recurrence and typology of acute symptoms. Familial history and systemic or nasal symptoms were considered as the first step to define the right profile. We obtained a subjective evaluation of nasal obstruction from every patient using a visual analogic scale (1 -10). ENT examination was performed by anterior and posterior rhinoscopy. In most cases we used a flexible or rigid optic fibre endoscope. Every patient underwent anterior rhinomanometric examination (AAR) with RHINO MENFIS and acoustic rhinometry (AR) with RHINOCLACK 1000 apparatuses. When total nasal resistance exceeded 0.50 Pa ml=s at 150 Pa, we repeated the examination after giving nasal decongestant (tramazoline hydrochlorid) -two puffs= nostril.
The study of nasal function was completed with nasal mucociliary transport time evaluation (nMCT). nMCT is evaluated by a mixture of charcoal powder and saccharine 3% (Passàli et al; 1984) . We place the tracer on the head of the inferior turbinate measuring the time it takes to reach the oropharynx. The diagnosis of allergic rhinitis was performed by prick test (first level investigation; Kit LOFARMA, Milano, Italy) with the most common inhalant allergens of our region (Graminae, Dermatophagoides Pteronissimus (DpP), Parietaria officinalis, Olea europaea and Cupressus sempervirens).
Of the 13 subjects enrolled, three were sensitive only to Graminae, one to cypress tree, and one to DpP; while the other eight presented multiple sensitizations variously combined, DpP, Parietaria, olive tree, cypress tree and the epithelium and forms of cat dandruff. Accordingly the sample selected is considered as varied and representative of the local allergic population. The dosage of specific IgE blood levels was performed in each patient by radioimmunologic method (RAST; second level investigation).
Allergenic sensibility was confirmed by nasal specific provocation test (NPT) to the allergens suggested by prick tests: allergens were administered topically as liophilized powder dispersed in lactose at increasing dosages (20 -40 -60 AU); the nasal provocation test was considered positive when the nasal resistance, in the tested fossa, increased by 100% or more, and=or in the presence of a typical symptomatologic crisis (sneezing, rhinorrhea, nasal obstruction; third level investigation).
All the subjects enrolled were requested to fill in a preprinted form supplied by ourselves to be updated monthly, giving the symptomatological score according to a system of points, ranging from 1 to 10 on the basis of the symptoms present: nasal obstruction, itching, sneezing and rhinorrhea.
These preliminary tests excluded patients in whom nasal obstruction was related to septal deviation or nasal polyposis and patients affected by systemic disorders not compatible with our study.
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Experimental design
Subjects participating to the study were divided into three groups as follows: group I included seven allergic rhinopathic patients (three male, four female) who underwent yoghurt feeding (three jars of 150 g each, daily) for 4 months, group II included seven allergic rhinopatic patients (five male, two female) who underwent partial skimmed milk feeding (three lots of 150 ml each, daily) for 4 months, (one man dropped out of the study), group III included healthy subjects with functional nasal respiratory values and blood IgE levels within the normal range. Of this control group only three subjects (two male, one female) of the initial five could be fully evaluated, while four could be evaluated at a later stage only for nMCT and the symptomatologic score.
Composition of yoghurt
Yoghurt labelled Kyr# produced by Parmalat (Parma, Italy) was checked at the factory, distributed weekly and kept at about þ 4 C before use. This product is basically traditional yoghurt containing two typical bacteria: Lactobacillus delbruekii, sub bulgaricus and Streptococcus thermophilus. Moreover, it contains two probiotic bacteria, Lactobacillus acidophylus and Bifidobacterium and can be considered as a potentiated yoghurt. Table 1 summarizes the composition. Partially skimmed milk had a very similar composition but no bacteria.
The experimental period went from March to October 1999 as not all subjects could be recruited at the same time. In order to highlight the slightest variations in the mediators of immunophlogosis, we considered it necessary for patients to begin taking yoghurt and milk under conditions of relative symptomatological well-being. For this reason and so as to eliminate any interferences by viral infections (acute rhinitis, bouts of influenza) or bacterial infections (acute and chronic sinusites) characteristic of the cold months with specific nasal hyperreactivity, the start of the study was planned for the end of the winter and before the pollen season.
During the specific feeding period every patient completed a questionnaire noting relevant symptomatologic variations, adverse reactions, or deviations from the feeding protocol. Compliance was excellent and only one dropped out of the study. Patients were not taking any other drugs during the experimental period.
At the end of the 4 month period, all subjects were submitted again to the same nasal functionality tests and first, second and third level allergologic tests.
Laboratory analyses
As mentioned before, 25 ml of blood were withdrawn in heparin before and after the experimental period. However the four healthy subjects enrolled at a late stage did not undergo this analysis. Blood was processed immediately as follows.
Cell separation and culture
The preparation of the peripheral blood mononuclear cells (PBMC) was performed according to the Boyum's (1968) method. Briefly, the heparinized blood was diluted 1 : 1 with phosphate-buffered saline (PBS), layered over Lymphoprep (Nycomed Pharma AS, Oslo, Norway) and centrifuged at 800 g for 30 min at room temperature. After the centrifugation PBMC were removed, washed in PBS and centrifuged twice at 300 g for 10 min. The cells were then resuspended in RPMI 1640 medium (Sigma) supplemented with 10% heatinactivated foetal calf serum (Sigma), 100 U=ml penicillin, 100 mg=ml streptomycin, and 2 mM L-glutamine at a final concentration of 1.5Â10 6 . Cells were distributed (200 ml=well) in 96-well culture plates (Costar, Badhoeverdorp, The Netherlands) and placed in an air:CO 2 (95 : 5%) incubator (KW srl, Siena, Italy) saturated with water at temperature of 37 C for 40 and 64 h, representing an optimal time for cytokine production. An equivalent amount of cells were treated with 5 mg=ml of phytohemagglutinin P (PHA-P, Sigma). At the end of the incubation times, plates were centrifuged at 300 g and the supernatants collected and stored at 7 80 C until cytokine determination.
Proliferation index assay
The cell proliferation was measured with the ELISA kit BrdU (Boehring-Mannheim, Germany). Briefly, cells were incubated with BrdU labelling for 3 h. During this period the pyrimidine analogue BrdU was incorporated in place of thymidine into the DNA of proliferating cells. After removing the culture medium, cells were fixed and the DNA denatured. The anti-BrdU-POD binds to the BrdU incorporated in newly synthesized cellular DNA. Immune complexes were then detected by subsequent substrate-enzyme reaction. The product is quantified by measuring the absorbance at a wavelength of 450 nm and a reference wavelength of 620 nm with a Multiskan microplate reader (Titertek, Flow Laboratories, Helsinki, Finland). Proliferation index was cal- Average values checked after production and during correct storage; for immunological activity a concentration of almost 1.0Â10 6 ufc=g is recommended (Tamime et al, 1995) .
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Cytokine determination
Cytokine were determined using immunoenzymatic methods. The commercial enzyme-linked immunosorbent assays were: Euroclone IL-4 and IFN-g ELISA kits. The minimum detectable doses were 10 pg=ml for IFN-g and 0.5 pg=ml for IL-4. Kit standards; supernatants of either normal or PHA stimulated PBMC were appropriately diluted with the standard dilution buffer of the kit. A three cycle automatic washing was routinely performed. The evaluation of the proliferation index (PI), of cytokine (IFN g and IL-4) production and plasma levels was similarly carried out 1 -2 days before and after the end of the experimental period.
Statistical analysis
No differences between men and women were noted and all data were pooled together. Statistical evaluation of the experimental data was performed with two-tailed Student's t-test for paired samples with P < 0.05 as the minimum level of significance.
Results
Immunological results
Values of the proliferation index performed after 40 and 64 h incubation do not show any significant difference among the three groups, reinforcing the notion that even the potentiated yoghurt rich in probiotics is a very weak immunoenhancer in comparison to PHA. Nonetheless the results showing the production of IFN g by PBMC before and after yoghurt feeding are interesting: it appears that IFN g in unstimulated PBMC increases almost 9-(40 h) fold and 3.5-fold (64 h) but, owing to the high interindividual variability, data do not reach statistical significance (Figure 1 ). The control group does not show any cytokine modification. After PHA stimulation, as expected, the production of IFN g appears somewhat down-regulated (Figure 1, lower panel) . Results regarding IL-4 are also informative: basal production of IL-4 in atopic subjects does not appear significantly higher that normal subjects and this has been an unexpected finding. Both yoghurt and milk feeding for 4 months have hardly modified the production that is only minimally decreased (Figure 2 ). The stimulation with PHA was more revealing because it yielded a far higher level of IL-4 in atopic than normal subjects (Figure 2, lower panel) . After 40 h incubation, production of IL-4 was almost halved and this result was more evident after yoghurt than milk feeding. It is unclear why IL-4 levels were considerably reduced after 64 h incubation unless this is due to IL-4 degradation. Evaluation of both cytokines' levels in plasma has been totally negative in the sense that they were at and remained at almost undetectable levels throughout the study.
Clinical results
Prick tests. Repetition of the tests at 4 months failed to show any significant modifications in cutaneous sensitivity either for the subjects who had taken milk, or those who had taken yoghurt.
Rhinomanometry -acoustic rhinometry. It is important to point out that we could not expect these examinations to show an improvement in breathing through the nose following the taking of yoghurt; under basal conditions a situation of relative symptomatological well-being had already given values of nasal resistance within normal limits.
From this point of view the substantially unaltered results obtained at the end of the period of study should be considered as a positive finding; it should not be forgotten that this period coincided with the pollen season, which is the problematic time for the allergic patient. While, therefore, it Figure 1 IFNg production shown by PBMC after 40 and 60 h incubation. All experimental samples plus average are compared to control before (pre) and after (post) the 4 month experimental period (top). Values of IFNg production after PHA stimulation (low panel).
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C Aldinucci et al would have been logical to expect a worsening of the nasal functionality tests, the results obtained enable us to suggest that the dairy products may in some way have weakened the seasonal allergic impact. From the statistical viewpoint, there were no statistically significant differences between the two groups, even if in the group which had taken yoghurt, basal nasal resistances were on an average higher than normal.
Muco-ciliary clearance. MCTt represents an excellent parameter of the eutrophism of the respiratory mucosa: the system of aspecific defence, consisting of the interaction between the mucus layer over the epithelium and the metachronous movement of the vibratile cilia, is the first to be affected by any external attacks such as the alteration of the composition of secretions or through direct damage to the cilia. In the course of the allergic crisis the secretions become more abundant and liquid, impeding an efficient ciliary movement and, as a consequence, clearance of the secretions themselves.
In our sample the values for MCTt were on an average within the normal range already under basal conditions, remaining practically unchanged at the end of the study in both groups (Table 2) . Following more careful examination and statistical inquiry using the Student t-test, a statistically significant difference was found for the MCTt values, which appear to have improved following the ingestion of yoghurt, compared to being substantially constant in the group that took milk.
First level allergometric tests (prick tests).
The repetition of the cutaneous tests at the end of the period of study (4 months) confirmed the positivities noted at enrolment without any noteworthy modifications of the dimensions of the pomphus either in the group taking yoghurt or in the group taking milk. Dosage of the specific serum IgEs (RAST). The dosage of the specific IgEs was carried out in all subjects for the all allergens that had caused a cutaneous reaction on the prick tests at the beginning and end of the study. The analysis of the results shows that the taking of yoghurt failed to cause significant variations in the dosages of serum immunoglobulins.
Apart from this, such a dosage merely gives evidence of the contact of the allergic subject with the specific allergen, but may not agree with the clinical results and with the Nasal provocation test (NPT). NPT proposes defining the degree of reactivity of the nasal mucosa through determination of the threshold dose or, in other words, the quantity of allergens, administered locally, capable of setting off the allergic response. In the subjects studied the examination was carried out for one single allergen and, in the case of polysensitization, the allergen that had given a greater cutaneous response. Repetition of the NPT at the end of the study showed a substantial constancy of results; the small variations recorded in post-treatment controls are present in both groups without any statistically significant differences.
Symptomatological score. The analysis of the questionnaires for the recording of the symptomatological score (Table 3 ) drawn up by the patient every 4 weeks throughout the duration of the study, made it possible to arrive at interesting conclusions: overall there was a clear presence of an almost constant improvement in both groups; however the more marked subjective improvement occurred in the subjects who had taken yoghurt. In order to appraise its statistical significance, we applied the Student t-test to the averages of the scores recorded in the first questionnaire and those obtained at the end of the study. The test points to a statistically significant difference between the two groups, in favour of the subjects who had taken the yoghurt. Accordingly, all the subjects passed through the period of pollinosis without any worsening of their allergic symptomatology and, since this effect was more apparent in the group undergoing treatment with yoghurt, the result cannot be attributed to a particularly favourable season. Apart from this, it is impossible to discriminate what proportion of the subjective sensation of marked improvement is due to the placebo effect in the subjects who took yoghurt, in whom, in any case, a condition of well-being was created, to which confirmation of an objective type may be added, with improvement in the MCT time.
Discussion
The possible influence of yoghurt consumption has been a subject of numerous investigations attempting to demonstrate a mild immunoregulatory or enhancing effect in atopic and elderly adults. It seems likely that yoghurt acts in a multifactorial fashion by either establishing an ideal bacterial flora or=and by containing an array of compounds derived both from the bacteria and fermented milk able to interact with the GALT that comprises almost 40% of the total immunocytes. Obviously the effect of yoghurt may become visible only after prolonged administration and may depend on the quality and amount ingested daily, by the type of concomitant diet and by many other factors such as age, sex and immune responsiveness.
These simple considerations added to some methodological pitfalls, such as the too short duration of most of the studies and the lack of fool-proof indicators of immune response, help to show why results are somewhat controversial and difficult to interpret. We have attempted to overcome these difficulties by using a yoghurt enriched with two important probiotics which are considered relevant for inducing beneficial effects, particularly for normalizing the bacterial flora and correcting a dysimmune state. However the unavoidable heterogeneity of patients compounds the problem, which could be partly overcome by increasing the number of patients (not possible in our study). Actually the withdrawl of two healthy subjects partly later replaced by other subjects unbalanced the statistical evaluation. However, in spite of these drawbacks, it appears that the daily ingestion of a conspicuous volume of potentiated yoghurt procures a substantial change in cytokine release in rhinopathic patients: production of either IFN g or IL-4 from unstimulated PBMC was markedly either increased or decreased after 40 and 64 h incubation, respectively, which may be helpful in re-equilibrating the immune system. It is of interest to note that partially skimmed milk, which obviously does neither contain bacteria or bacterial products, did not modify the cytokine pattern. Moreover we have shown that evaluation of plasmatic levels are not informative in patients with modest regional atopy. This result is not surprising as we could show an enhanced production of IFN g only in vitro. However the activation is so mild that, by Effect of yoghurt in rhinopathic patients C Aldinucci et al considering the rapid turnover of cytokines (Bocci, 1994) , the increased production cannot be translated into elevated plasma levels. As expected, some of the clinical results (prick tests, IgEs plasma levels) were unchanged, but the MCTt and the symptomatological score showed an improvement in yoghurt-fed subjects. It is also possible that beneficial results have been underestimated because the period of study coincided with the critical time for allergic recurrences.
